Ferdinandos Skoulidis
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers 20
- Colorectal Cancer Treatments and Studies 19
- Lung Cancer Research Studies 6
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 13
-
- Lung Cancer Treatments and Mutations 45
- Lung Cancer Diagnosis and Treatment 6
- Molecular Biology top 5%
- Cancer therapeutics and mechanisms 9
- Immunology top 10%
-
- Genetic factors in colorectal cancer 6
- Co-authors
- John V. HeymachJames W. WelshJing WangAshok R. VenkitaramanJoe Y. ChangVivek VermaGeorge R. SimonDawei Chen
- Journals
- Nature Communications (1 paper)Journal of Clinical Oncology (17 papers)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
Ferdinandos Skoulidis
66 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Oncology 1.8k
- Cancer Research 729
- Pulmonary and Respiratory Medicine 1.4k
- Molecular Biology 1.4k
- Immunology 376
Countries citing papers authored by Ferdinandos Skoulidis
This map shows the geographic impact of Ferdinandos Skoulidis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ferdinandos Skoulidis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ferdinandos Skoulidis more than expected).
Fields of papers citing papers by Ferdinandos Skoulidis
This network shows the impact of papers produced by Ferdinandos Skoulidis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ferdinandos Skoulidis. The network helps show where Ferdinandos Skoulidis may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ferdinandos Skoulidis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 48 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 0 | |
| 9 | 2021 | 1 | |
| 10 | 2021 | 8 | |
| 11 | 2020 | 20 | |
| 12 | 2020 | 29 | |
| 13 | 2020 | 112 | |
| 14 | 2019 | 215 | |
| 15 | Co-occurring genomic alterations in non-small-cell lung cancer biology and therapybreakdown → | 2019 | 630 |
| 16 | 2019 | 57 | |
| 17 | 2017 | 7 | |
| 18 | 2016 | 64 | |
| 19 | 2011 | 15 | |
| 20 | 2005 | 38 |
About Ferdinandos Skoulidis
Ferdinandos Skoulidis is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 73 papers that have together received 3.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (45 papers), Cancer Immunotherapy and Biomarkers (20 papers), Colorectal Cancer Treatments and Studies (19 papers), Cancer Genomics and Diagnostics (13 papers), Cancer therapeutics and mechanisms (9 papers), Lung Cancer Diagnosis and Treatment (6 papers), Genetic factors in colorectal cancer (6 papers) and Lung Cancer Research Studies (6 papers). The work is most often cited by research in Oncology (1.8k citations), Cancer Research (729 citations) and Pulmonary and Respiratory Medicine (1.4k citations). Ferdinandos Skoulidis has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include John V. Heymach, James W. Welsh, Jing Wang, Ashok R. Venkitaraman, Joe Y. Chang, Vivek Verma, George R. Simon, Dawei Chen, Vassiliki A. Papadimitrakopoulou and Venkat Pisupati. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.